An assessment of interactions between global health initiatives and country health systems

World Health Organization Maximizing Positive Synergies Collaborative Group

Research output: Contribution to journalArticle

Abstract

Since 2000,the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources,whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far,most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data,and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far,and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings,we make some general recommendations and identify a series of action points for international partners,governments,and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work,and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close,and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency,equity,value for money,and outcomes in global public health,then these opportunities should not be missed.

Original languageEnglish (US)
Pages (from-to)2137-2169
Number of pages33
JournalThe Lancet
Volume373
Issue number9681
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Health
Public Health
Anecdotes
Social Adjustment
Global Health
Economics
Efficiency

ASJC Scopus subject areas

  • Medicine(all)

Cite this

World Health Organization Maximizing Positive Synergies Collaborative Group (2009). An assessment of interactions between global health initiatives and country health systems. The Lancet, 373(9681), 2137-2169. https://doi.org/10.1016/S0140-6736(09)60919-3

An assessment of interactions between global health initiatives and country health systems. / World Health Organization Maximizing Positive Synergies Collaborative Group.

In: The Lancet, Vol. 373, No. 9681, 2009, p. 2137-2169.

Research output: Contribution to journalArticle

World Health Organization Maximizing Positive Synergies Collaborative Group 2009, 'An assessment of interactions between global health initiatives and country health systems', The Lancet, vol. 373, no. 9681, pp. 2137-2169. https://doi.org/10.1016/S0140-6736(09)60919-3
World Health Organization Maximizing Positive Synergies Collaborative Group. An assessment of interactions between global health initiatives and country health systems. The Lancet. 2009;373(9681):2137-2169. https://doi.org/10.1016/S0140-6736(09)60919-3
World Health Organization Maximizing Positive Synergies Collaborative Group. / An assessment of interactions between global health initiatives and country health systems. In: The Lancet. 2009 ; Vol. 373, No. 9681. pp. 2137-2169.
@article{aea93b9ca6e44e9ea501597bee926282,
title = "An assessment of interactions between global health initiatives and country health systems",
abstract = "Since 2000,the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources,whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far,most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data,and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far,and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings,we make some general recommendations and identify a series of action points for international partners,governments,and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work,and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close,and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency,equity,value for money,and outcomes in global public health,then these opportunities should not be missed.",
author = "{World Health Organization Maximizing Positive Synergies Collaborative Group} and Badara Samb and Tim Evans and Mark Dybul and Rifat Atun and Moatti, {Jean Paul} and Sania Nishtar and Anna Wright and Francesca Celletti and Justine Hsu and Kim, {Jim Yong} and Ruairi Brugha and Asia Russell and Carissa Etienne and Susna De and Takondwa Mwase and Wenjuan Wang and Jenna Wright and Lola Dar{\'e} and Delfraissy, {Jean Fran{\cc}ois} and Fran{\cc}ois Boillot and Pierre Miege and Xiulan Zhang and Joseph Rhatigan and Rebecca Weintraub and Sok Pun and C. Ab{\'e} and Carlos Caceres and Mamadou Camara and Benjamin Coriat and Cristina D’Almeida and Julia Aleshkina and Gulgun Murzalieva and John Kadzandira and N. Hammami and Victor Mwapasa and Ketevan Chkhatarashvili and Eric Buch and Katabaro Miti and Claudes Kamenga and Elouma, {Marthe Sylvie Essengue} and Nina Schwalbe and Alan Greenberg and Seble Frehywot and Anne Markus and Lieve Goeman and Alia Khan and Jael Amati and Esther Mwaura-Muiru and Ivers, {Louise C.} and Krishna Rao",
year = "2009",
doi = "10.1016/S0140-6736(09)60919-3",
language = "English (US)",
volume = "373",
pages = "2137--2169",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9681",

}

TY - JOUR

T1 - An assessment of interactions between global health initiatives and country health systems

AU - World Health Organization Maximizing Positive Synergies Collaborative Group

AU - Samb, Badara

AU - Evans, Tim

AU - Dybul, Mark

AU - Atun, Rifat

AU - Moatti, Jean Paul

AU - Nishtar, Sania

AU - Wright, Anna

AU - Celletti, Francesca

AU - Hsu, Justine

AU - Kim, Jim Yong

AU - Brugha, Ruairi

AU - Russell, Asia

AU - Etienne, Carissa

AU - De, Susna

AU - Mwase, Takondwa

AU - Wang, Wenjuan

AU - Wright, Jenna

AU - Daré, Lola

AU - Delfraissy, Jean François

AU - Boillot, François

AU - Miege, Pierre

AU - Zhang, Xiulan

AU - Rhatigan, Joseph

AU - Weintraub, Rebecca

AU - Pun, Sok

AU - Abé, C.

AU - Caceres, Carlos

AU - Camara, Mamadou

AU - Coriat, Benjamin

AU - D’Almeida, Cristina

AU - Aleshkina, Julia

AU - Murzalieva, Gulgun

AU - Kadzandira, John

AU - Hammami, N.

AU - Mwapasa, Victor

AU - Chkhatarashvili, Ketevan

AU - Buch, Eric

AU - Miti, Katabaro

AU - Kamenga, Claudes

AU - Elouma, Marthe Sylvie Essengue

AU - Schwalbe, Nina

AU - Greenberg, Alan

AU - Frehywot, Seble

AU - Markus, Anne

AU - Goeman, Lieve

AU - Khan, Alia

AU - Amati, Jael

AU - Mwaura-Muiru, Esther

AU - Ivers, Louise C.

AU - Rao, Krishna

PY - 2009

Y1 - 2009

N2 - Since 2000,the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources,whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far,most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data,and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far,and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings,we make some general recommendations and identify a series of action points for international partners,governments,and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work,and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close,and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency,equity,value for money,and outcomes in global public health,then these opportunities should not be missed.

AB - Since 2000,the emergence of several large disease-specific global health initiatives (GHIs) has changed the way in which international donors provide assistance for public health. Some critics have claimed that these initiatives burden health systems that are already fragile in countries with few resources,whereas others have asserted that weak health systems prevent progress in meeting disease-specific targets. So far,most of the evidence for this debate has been provided by speculation and anecdotes. We use a review and analysis of existing data,and 15 new studies that were submitted to WHO for the purpose of writing this Report to describe the complex nature of the interplay between country health systems and GHIs. We suggest that this Report provides the most detailed compilation of published and emerging evidence so far,and provides a basis for identification of the ways in which GHIs and health systems can interact to mutually reinforce their effects. On the basis of the findings,we make some general recommendations and identify a series of action points for international partners,governments,and other stakeholders that will help ensure that investments in GHIs and country health systems can fulfil their potential to produce comprehensive and lasting results in disease-specific work,and advance the general public health agenda. The target date for achievement of the health-related Millennium Development Goals is drawing close,and the economic downturn threatens to undermine the improvements in health outcomes that have been achieved in the past few years. If adjustments to the interactions between GHIs and country health systems will improve efficiency,equity,value for money,and outcomes in global public health,then these opportunities should not be missed.

UR - http://www.scopus.com/inward/record.url?scp=67249115636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67249115636&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(09)60919-3

DO - 10.1016/S0140-6736(09)60919-3

M3 - Article

C2 - 19541040

AN - SCOPUS:67249115636

VL - 373

SP - 2137

EP - 2169

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9681

ER -